EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Spillover effects from a type 2 diabetes integrated model of care in 22,706 Australians: an open cohort stepped wedge trial

Shamasunder Acharya, Rachael Taylor, Martha Parsons, John Attia, Lucy Leigh, Christopher Oldmeadow, Katie Wynne, Christopher Rowe, Morag Joseph, Judy Luu, Annalise Philcox, Damien Jackel und 4 weitere

BMC Endocrine Disorders · 2024

DOI: 10.1186/s12902-024-01692-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BMC Endocrine Disorders, 2024. Verfasst von Shamasunder Acharya und 15 weiteren Autor:innen. Beteiligte Einrichtung: Hunter New England Health District, John Hunter Hospital, Lookout Road, New Lambton Heights, NSW, 2305, Australia. Shamasunder.Acharya@health.nsw.gov…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Delivery of Health Care, Integrated. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Many Australian adults are not receiving timely or effective diabetes management to prevent or delay the onset of diabetes related complications. Integrated care, a worldwide trend in healthcare reform, aims to reduce the fragmented delivery of health services and improve outcomes. This study aimed to test whether a specialist-led integrated model of care provided to a small subset of patients in general practices leads to spillover clinical improvements in all patients of the practice with type 2 diabetes.

Methods

Seventy-two general practice sites (clusters) in New South Wales, Australia received the Diabetes Alliance intervention, creating a non-randomised open cohort stepped wedge trial. The intervention comprised of case conferencing, delivered directly to a small proportion of adults with type 2 diabetes ( n = 1,072) of the general practice sites; as well as practice feedback, education and training. Spillover clinical improvements were assessed on all adults with type 2 diabetes within the general practice sites ( n = 22,706), using practice level data recorded in the MedicineInsight electronic database, compared before and after the intervention. Outcome measures included frequency of diabetes screening tests in line with the Annual Cycle of Care, and clinical results for weight, blood pressure, HbA1c, lipids, and kidney function.

Results

Compared to before Diabetes Alliance, the odds of all practice patients receiving screening tests at or above the recommended intervals were significantly higher for all recommended tests after Diabetes Alliance (odds ratio range 1.41–4.45, p < 0.0001). Significant improvements in clinical outcomes were observed for weight (absolute mean difference: -1.38 kg), blood pressure (systolic − 1.12 mmHg, diastolic − 1.18 mmHg), HbA1c (-0.03% at the mean), total cholesterol (-0.11 mmol/L), and triglycerides (-0.02 mmol/L) ( p < 0.05). There were small but significant declines in kidney function.

Conclusions

Integrated care delivered to a small subset of patients with type 2 diabetes across a large geographic region has spillover benefits that improve the process measures and clinical outcomes for all practice patients with type 2 diabetes.

Trial registration

ACTRN12622001438741; 10th November 2022, retrospectively registered: https://www.anzctr.org.au/ACTRN12622001438741.aspx .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Delivery of Health Care, IntegratedHumansMaleFemaleMiddle AgedAgedAustraliaAdultCohort StudiesNew South WalesGeneral PracticeFollow-Up StudiesAustralasian People

Stichwörter der Autor:innen

Outcome assessmentClinical trialDiabetes mellitusGeneral practiceHealth servicesType 2

Autor:innen und Institutionen

  • Hunter New England Health District, John Hunter Hospital, Lookout Road, New Lambton Heights, NSW, 2305, Australia. Shamasunder.Acharya@health.nsw.gov.au.
  • School of Medicine and Public Health, University of Newcastle, University Drive, Callaghan, NSW, 2308, Australia. Shamasunder.Acharya@health.nsw.gov.au.
  • Hunter Medical Research Institute, New Lambton Heights, NSW, 2305, Australia. Shamasunder.Acharya@health.nsw.gov.au.
  • School of Medicine and Public Health, University of Newcastle, University Drive, Callaghan, NSW, 2308, Australia.
  • Hunter Medical Research Institute, New Lambton Heights, NSW, 2305, Australia.
  • Hunter New England Health District, John Hunter Hospital, Lookout Road, New Lambton Heights, NSW, 2305, Australia.

Zitieren

APA

Acharya, S., Taylor, R., Parsons, M., Attia, J., Leigh, L., Oldmeadow, C., Wynne, K., Rowe, C., Joseph, M., Luu, J., Philcox, A., Jackel, D., Quach, T., Sankoorikal, C., Dagg, S., & Hure, A. (2024). Spillover effects from a type 2 diabetes integrated model of care in 22,706 Australians: an open cohort stepped wedge trial. BMC Endocrine Disorders. https://doi.org/10.1186/s12902-024-01692-4

Vancouver

Acharya S, Taylor R, Parsons M, Attia J, Leigh L, Oldmeadow C, et al. Spillover effects from a type 2 diabetes integrated model of care in 22,706 Australians: an open cohort stepped wedge trial. BMC Endocrine Disorders. 2024. doi:10.1186/s12902-024-01692-4

BibTeX
@article{Acharya2024,
  author = {Acharya, Shamasunder and Taylor, Rachael and Parsons, Martha and Attia, John and Leigh, Lucy and Oldmeadow, Christopher and Wynne, Katie and Rowe, Christopher and Joseph, Morag and Luu, Judy and Philcox, Annalise and Jackel, Damien and Quach, Tuan and Sankoorikal, Christy and Dagg, Simone and Hure, Alexis},
  title = {Spillover effects from a type 2 diabetes integrated model of care in 22,706 Australians: an open cohort stepped wedge trial},
  journal = {BMC Endocrine Disorders},
  year = {2024},
  doi = {10.1186/s12902-024-01692-4}
}
Kostenlos starten →